A new commentary in the Georgian Medical Journal has established comprehensive ethical and legal safeguards for including critically ill patients in clinical research. The analysis, authored by Giorgi Pkhakadze, demonstrates that Georgian regulatory requirements fully align with international best practices, providing reassurance that national legislation adequately protects one of medicine’s most vulnerable populations.
Critically ill patients face unique research risks due to impaired decision-making capacity, therapeutic misconception, and power imbalances with treating clinicians. The commentary identifies three mandatory core requirements: independent ethical review, informed consent, and proportional risk–benefit assessment. By establishing clear standards that meet both domestic and global expectations, this framework strengthens research governance and ensures that critically ill patients receive heightened ethical protection throughout their participation in clinical trials.
Read the full article on GMJ Newsroom.
Was this article helpful?
